Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hematologic Diseases × Interviews as Topic × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Neoplasms 17 Breast Neoplasms 14 Prostatic Neoplasms 13 Colorectal Neoplasms 13 Lung Neoplasms 9 Hematopoietic and Lymphatic System Neoplasm 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Multiple Myeloma 4 Malignant Solid Neoplasm 4 Depression 4 Uterine Cervical Neoplasms 3 Lymphoma 3 Hematopoietic and Lymphoid System Neoplasm 3 Hematologic Neoplasms 3 Anxiety Disorders 3 Anatomic Stage I Breast Cancer AJCC v8 3 Advanced Malignant Solid Neoplasm 3 Urinary Bladder Neoplasms 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Motor Activity 2 Leukemia 2 Laryngeal Neoplasms 2 Head and Neck Carcinoma 2 Gastrointestinal Neoplasms 2 Endometrial Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2

Interventions

Cyclophosphamide 18 Brentuximab Vedotin 17 fludarabine 14 Rituximab 10 Melphalan 10 Lenalidomide 10 Busulfan 10 fludarabine phosphate 9 Mycophenolic Acid 9 Dexamethasone 9 Whole-Body Irradiation 7 Tacrolimus 7 pirtobrutinib 6 dacetuzumab 6 Bortezomib 6 ruxolitinib 5 Imatinib Mesylate 5 Doxorubicin 5 Azacitidine 5 ponatinib 4 Vincristine 4 Prednisone 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Etoposide 4 Bone Marrow Transplantation 4 nilotinib 3 lintuzumab 3 ibrutinib 3 Vorinostat 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03272789 2019-01-23

REBOND

Institut Paoli-Calmettes

Phase NA Unknown

Hematologic Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡